Additionally, the List provides other information obtained through public health official notifications, such as:
A public health official notification allows a listed drug to be imported into Canada and sold in the notifying jurisdiction for one year. If the notification is not renewed within one year, the drug will no longer be eligible for importation and sale. The Minister also has the discretion to remove drugs from the List at any time.
List of Drugs for an Urgent Public Health Need
Brand Name | Medicinal Ingredient(s) | Dosage Form | Strength | Route of Administration | Foreign Identifying Code or Number | For Information Purposes |
---|---|---|---|---|---|---|
Priftin | Rifapentine | Tablet | 150mg | Oral | 0088-2100-24 | FDA/USA Footnote1 Important foreign identified risk information-see footnote below First Nations and Inuit Health Branch / May 23, 2024 Tuberculosis crisis – For the treatment of latent tuberculosis infection (LTBI) caused by Mycobacterium tuberculosis in combination with isoniazid in patients at high risk of progression to TB disease. |
Priftin | Rifapentine | Tablet | 150mg | Oral | 0088-2102-24 | FDA/USA Footnote1 Important foreign identified risk information-see footnote below Public Health Agency of Canada – for use in all jurisdictions / February 20, 2024 Tuberculosis crisis – For the treatment of latent tuberculosis infection (LTBI) caused by Mycobacterium tuberculosis in combination with isoniazid in patients at high risk of progression to TB disease. |